- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DarioHealth Corp (DRIO)
DarioHealth Corp stock price live, this page displays NASDAQ DRIO stock exchange data. View the DRIO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DarioHealth Corp real time stock price chart below.
What Is the DarioHealth Corp Stock Price Today?
The DarioHealth Corp stock price today is 7.568.
What Is the Stock Symbol for DarioHealth Corp?
The stock symbol for DarioHealth Corp is "DRIO."
What Stock Exchange Does DarioHealth Corp Trade On?
DarioHealth Corp is listed and trades on the NASDAQ stock exchange.
Is DarioHealth Corp a Good Stock to Buy?
Determining whether DarioHealth Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DRIO quote. (ISIN: US23725P3082)
What Is the DarioHealth Corp Stock Price Today?
The DarioHealth Corp stock price today is 7.568.
What Is the Stock Symbol for DarioHealth Corp?
The stock symbol for DarioHealth Corp is "DRIO."
What Stock Exchange Does DarioHealth Corp Trade On?
DarioHealth Corp is listed and trades on the NASDAQ stock exchange.
Is DarioHealth Corp a Good Stock to Buy?
Determining whether DarioHealth Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DRIO quote. (ISIN: US23725P3082)
7.568
-0.018(-0.23%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.285
7.940
52 wk Range
5.845
17.744
DRIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.2857.940
52 wk Range
5.84517.744
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DRIO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
14.500
Upside
+91.60%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14.500
(+91.60% Upside)
DarioHealth Corp Earnings Call Summary for Q2/2026
- DarioHealth beat Q2 2026 EPS forecast by 32% at -$0.85 vs. -$1.25 expected, but revenue missed by 14.1% at $5.18M vs. $6.03M consensus.
- Gross margin expanded to 62% from 55% year-over-year as company shifted away from low-margin pharma services toward recurring multi-condition contracts.
- Operating expenses fell 21% year-over-year; pro forma cash position reached $36.8M post-July financing with contracted ARR of $13.1M, 80% multi-condition.
- Management expects revenue acceleration in H2 2026 as signed contracts convert, with new GLP-1, Women's and Sleep programs contributing from Q4 2026 into 2027.
- Stock rose 4.93% to $7.66 despite remaining down 33% YTD; analysts maintain Buy rating with price targets of $10-$28, citing improved unit economics.
Last Updated: 2026/08/11, 15:22
Read Full TranscriptEarnings
Latest Release
Aug 11, 2026
EPS / Forecast
-0,85 / -1,25
Revenue / Forecast
5,18M / 6,03M
Compare DRIO to Peers and Sector
Metrics to compare | DRIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDRIOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.8x | −0.5x | −0.4x | |
PEG Ratio | −0.11 | 0.00 | 0.00 | |
Price/Book | 1.4x | 1.4x | 2.6x | |
Price / LTM Sales | 3.6x | 1.7x | 3.1x | |
Upside (Analyst Target) | 45.0% | 14.9% | 47.9% | |
Fair Value Upside | Unlock | 21.5% | 6.3% | Unlock |
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the DarioHealth (DRIO) Stock Price Today?
The DarioHealth stock price today is 7,568 USD.
What Stock Exchange Does DarioHealth Trade On?
DarioHealth is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for DarioHealth?
The stock symbol for DarioHealth is "DRIO."
What Is the DarioHealth Market Cap?
As of today, DarioHealth market cap is 74,160M USD.
What Is DarioHealth's Earnings Per Share (TTM)?
The DarioHealth EPS (TTM) is -0,947.
When Is the Next DarioHealth Earnings Date?
DarioHealth will release its next earnings report on Nov 16, 2026.
From a Technical Analysis Perspective, Is DRIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has DarioHealth Stock Split?
DarioHealth has split 4 times.
How Many Employees Does DarioHealth Have?
DarioHealth has 163 employees.
What is the current trading status of DarioHealth (DRIO)?
As of Aug 17, 2026, DarioHealth (DRIO) is trading at a price of 7,568 USD, with a previous close of 7,585 USD. The stock has fluctuated within a day range of 7,285 USD to 7,940 USD, while its 52-week range spans from 5,845 USD to 17,744 USD.
What Is DarioHealth (DRIO) Price Target According to Analysts?
The average 12-month price target for DarioHealth is 14,500 USD, with a high estimate of 28 USD and a low estimate of 8 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +91,60% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.